Bright Minds Biosciences Inc.
DRUG Nasdaq
SEC CIK 1827401
Follow Bright Minds Biosciences
Weekly email: filings, results, news
EPS, diluted
-
Source: SEC XBRL filings · latest filing
Show the numbers
| Year | Net income |
|---|---|
| FY24 | −CAD 2.8M |
| FY23 | −CAD 7.4M |
| FY22 | −CAD 15M |
| FY21 | −CAD 8.7M |
| FY20 | −CAD 480.4K |
| FY19 | - |
| FY18 | - |
News
No stories filed under Bright Minds Biosciences yet - coverage appears here as the news feed clusters it.